These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 25666606

  • 1. Sequential versus "sandwich" sequencing of adjuvant chemoradiation for the treatment of stage III uterine endometrioid adenocarcinoma.
    Lu SM, Chang-Halpenny C, Hwang-Graziano J.
    Gynecol Oncol; 2015 Apr; 137(1):28-33. PubMed ID: 25666606
    [Abstract] [Full Text] [Related]

  • 2. The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma.
    Jutzi L, Hoskins P, Lim P, Aquino-Parsons C, Tinker A, Kwon JS.
    Gynecol Oncol; 2013 Dec; 131(3):581-5. PubMed ID: 24055614
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation in intermediate- or high-risk endometrioid endometrial cancer: a single institution experience.
    Kim HS, Kim JW, Wu HG, Chung HH, Park NH, Song YS, Kang SB, Lee HP.
    J Obstet Gynaecol Res; 2010 Jun; 36(3):598-604. PubMed ID: 20598043
    [Abstract] [Full Text] [Related]

  • 4. Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.
    Milgrom SA, Kollmeier MA, Abu-Rustum NR, Tew WP, Sonoda Y, Barakat RR, Alektiar KM.
    Gynecol Oncol; 2013 Sep; 130(3):436-40. PubMed ID: 23800696
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant docetaxel and carboplatin chemotherapy administered alone or with radiotherapy in a "sandwich" protocol in patients with advanced endometrial cancer: a single-institution experience.
    Lan C, Huang X, Cao X, Huang H, Feng Y, Huang Y, Liu J.
    Expert Opin Pharmacother; 2013 Apr; 14(5):535-42. PubMed ID: 23480059
    [Abstract] [Full Text] [Related]

  • 6. Administration of concurrent vaginal brachytherapy during chemotherapy for treatment of endometrial cancer.
    Nagar H, Boothe D, Parikh A, Yondorf M, Parashar B, Gupta D, Holcomb K, Caputo T, Chao KS, Nori D, Wernicke AG.
    Int J Radiat Oncol Biol Phys; 2013 Nov 15; 87(4):665-9. PubMed ID: 24138915
    [Abstract] [Full Text] [Related]

  • 7. A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma.
    Onal C, Sari SY, Yildirim BA, Yavas G, Gultekin M, Guler OC, Akyurek S, Yildiz F.
    J Gynecol Oncol; 2019 May 15; 30(3):e28. PubMed ID: 30887753
    [Abstract] [Full Text] [Related]

  • 8. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM, Venkatraman E, Chi DS, Barakat RR.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):111-7. PubMed ID: 15850910
    [Abstract] [Full Text] [Related]

  • 9. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
    Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T, Radiation Therapy Oncology Group.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):168-73. PubMed ID: 15093913
    [Abstract] [Full Text] [Related]

  • 10. Comparison of "sandwich chemo-radiotherapy" and six cycles of chemotherapy followed by adjuvant radiotherapy in patients with stage IIIC endometrial cancer: a single center experience.
    Dogan NU, Yavas G, Yavas C, Ata O, Yılmaz SA, Celik C.
    Arch Gynecol Obstet; 2013 Oct 01; 288(4):845-50. PubMed ID: 23553195
    [Abstract] [Full Text] [Related]

  • 11. Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer.
    Wilkinson-Ryan I, Binder PS, Pourabolghasem S, Al-Hammadi N, Fuh K, Hagemann A, Thaker P, Schwarz J, Grigsby P, Mutch D, Powell M.
    Gynecol Oncol; 2014 Jul 01; 134(1):24-8. PubMed ID: 24823648
    [Abstract] [Full Text] [Related]

  • 12. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.
    Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S, Kudo R, Japanese Gynecologic Oncology Group.
    Gynecol Oncol; 2008 Jan 01; 108(1):226-33. PubMed ID: 17996926
    [Abstract] [Full Text] [Related]

  • 13. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.
    Duska LR, Berkowitz R, Matulonis U, Muto M, Goodman A, McIntyre JF, Klein A, Atkinson T, Seiden MV, Campos S.
    Gynecol Oncol; 2005 Jan 01; 96(1):198-203. PubMed ID: 15589601
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
    Lupe K, D'Souza DP, Kwon JS, Radwan JS, Harle IA, Hammond JA, Carey MS.
    Gynecol Oncol; 2009 Jul 01; 114(1):94-8. PubMed ID: 19406459
    [Abstract] [Full Text] [Related]

  • 15. Neoadjuvant radiotherapy with or without chemotherapy followed by extrafascial hysterectomy for locally advanced endometrial cancer clinically extending to the cervix or parametria.
    Vargo JA, Boisen MM, Comerci JT, Kim H, Houser CJ, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Huang M, Courtney-Brooks M, Beriwal S.
    Gynecol Oncol; 2014 Nov 01; 135(2):190-5. PubMed ID: 25218303
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
    de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Carinelli S, Provencher D, Hanzen C, Lutgens LCHW, Smit VTHBM, Singh N, Do V, D'Amico R, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL, PORTEC study group.
    Lancet Oncol; 2018 Mar 01; 19(3):295-309. PubMed ID: 29449189
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach.
    Lupe K, Kwon J, D'Souza D, Gawlik C, Stitt L, Whiston F, Nascu P, Wong E, Carey MS.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):110-6. PubMed ID: 17084542
    [Abstract] [Full Text] [Related]

  • 18. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
    Klopp AH, Jhingran A, Ramondetta L, Lu K, Gershenson DM, Eifel PJ.
    Gynecol Oncol; 2009 Oct 01; 115(1):6-11. PubMed ID: 19632709
    [Abstract] [Full Text] [Related]

  • 19. Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer.
    Dunn EF, Geye H, Platta CS, Gondi V, Rose S, Bradley KA, Anderson BM.
    Gynecol Oncol; 2014 Jun 01; 133(3):494-8. PubMed ID: 24657301
    [Abstract] [Full Text] [Related]

  • 20. Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.
    Young MR, Higgins SA, Ratner E, Yu JB, Mani S, Silasi DA, Azodi M, Rutherford T, Schwartz PE, Damast S.
    Int J Gynecol Cancer; 2015 Mar 01; 25(3):431-9. PubMed ID: 25621409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.